Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men
Clinical trial NCT02720094 · COMPLETED
Trial details
- NCT number
- NCT02720094
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-19
- Primary completion
- 2020-05-14
- Enrollment
- 4570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.